SE433804B - Forfarande for framstellning av en farmaceutisk lekemedelsberedning i kapselform med retardeffekt - Google Patents

Forfarande for framstellning av en farmaceutisk lekemedelsberedning i kapselform med retardeffekt

Info

Publication number
SE433804B
SE433804B SE7603325A SE7603325A SE433804B SE 433804 B SE433804 B SE 433804B SE 7603325 A SE7603325 A SE 7603325A SE 7603325 A SE7603325 A SE 7603325A SE 433804 B SE433804 B SE 433804B
Authority
SE
Sweden
Prior art keywords
pharmaceutical
preparing
procedure
preparation
pharmaceutical preparation
Prior art date
Application number
SE7603325A
Other languages
English (en)
Swedish (sv)
Other versions
SE7603325L (sv
Inventor
P R Sheth
J L Tossounian
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority claimed from KR7600645A external-priority patent/KR800001387B1/ko
Publication of SE7603325L publication Critical patent/SE7603325L/
Publication of SE433804B publication Critical patent/SE433804B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7603325A 1975-03-17 1976-03-16 Forfarande for framstellning av en farmaceutisk lekemedelsberedning i kapselform med retardeffekt SE433804B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55910775A 1975-03-17 1975-03-17
US65800376A 1976-02-13 1976-02-13
KR7600645A KR800001387B1 (en) 1975-03-17 1976-03-16 Process for preparing sustained release formulation

Publications (2)

Publication Number Publication Date
SE7603325L SE7603325L (sv) 1976-09-18
SE433804B true SE433804B (sv) 1984-06-18

Family

ID=27348140

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7603325A SE433804B (sv) 1975-03-17 1976-03-16 Forfarande for framstellning av en farmaceutisk lekemedelsberedning i kapselform med retardeffekt

Country Status (21)

Country Link
JP (1) JPS51115910A (ja)
AR (1) AR222624A1 (ja)
AT (1) AT353415B (ja)
AU (1) AU505355B2 (ja)
CA (1) CA1073358A (ja)
CH (1) CH630257A5 (ja)
DD (1) DD124102A5 (ja)
DE (1) DE2611041A1 (ja)
DK (1) DK148344C (ja)
ES (1) ES446075A1 (ja)
FR (1) FR2304354A1 (ja)
GB (1) GB1546448A (ja)
GR (1) GR60341B (ja)
IE (1) IE43083B1 (ja)
LU (1) LU74558A1 (ja)
MC (1) MC1101A1 (ja)
NL (1) NL190313C (ja)
NZ (1) NZ180321A (ja)
PH (1) PH14927A (ja)
PT (1) PT64907B (ja)
SE (1) SE433804B (ja)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
CH649215A5 (de) * 1981-04-29 1985-05-15 Hoffmann La Roche Pharmazeutische praeparate.
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
AU4064285A (en) * 1984-03-21 1985-10-11 American Home Products Corporation Sustained release pharmaceutical capsules
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
NL8600161A (nl) * 1985-02-05 1986-09-01 Sandoz Ag Farmaceutische preparaten die 9,10-dihydroergotalkaloiden bevatten.
GB8524135D0 (en) * 1985-10-01 1985-11-06 Sandoz Ltd Darodipine compositions
NL194822C (nl) * 1985-10-01 2003-04-03 Novartis Ag Preparaat voor orale toediening met geregelde afgifte en werkwijze voor de bereiding ervan.
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
SK282071B6 (sk) * 1991-01-30 2001-10-08 The Wellcome Foundation Limited Tableta dispergovateľná vo vode a spôsob jej prípravy
JP2626248B2 (ja) * 1991-04-08 1997-07-02 日本新薬株式会社 カプセル剤
ATE173159T1 (de) * 1992-03-25 1998-11-15 Depomed Systems Inc Auf hydroxyethylzellulose basierende oralen arzneidosisformen mit verzoegerter wirkstoffabgabe
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
CN1133558A (zh) * 1993-10-29 1996-10-16 雷克特和科尔曼产品有限公司 可发泡的明胶胶囊填充药物
WO1995011667A1 (en) * 1993-10-29 1995-05-04 R.P. Scherer Corporation Gelatin capsule fill able to foam
WO1995031186A1 (en) * 1994-05-13 1995-11-23 Smithkline Beecham Corporation Method and composition for increasing calcium uptake
JPH10509981A (ja) * 1994-12-01 1998-09-29 サイバス ファーマシューティカル,インコーポレイティド 高等植物から得られうる粉末状親水コロイドゴムを用いる持効性薬剤送出
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
FR2820318B1 (fr) * 2001-02-08 2005-12-23 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
FR2874325B1 (fr) * 2004-08-19 2006-10-20 Sanofi Synthelabo Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1059624B (de) * 1954-11-11 1959-06-18 Dr Knut Jacobus Sundman Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form
JPS5512411B2 (ja) * 1974-03-12 1980-04-02
DE2439538C3 (de) * 1974-08-17 1980-07-17 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe

Also Published As

Publication number Publication date
AR222624A1 (es) 1981-06-15
DD124102A5 (ja) 1977-02-02
IE43083L (en) 1976-09-17
DK148344B (da) 1985-06-17
DK113676A (da) 1976-09-18
FR2304354A1 (fr) 1976-10-15
DK148344C (da) 1985-11-04
FR2304354B1 (ja) 1979-04-27
JPS638084B2 (ja) 1988-02-19
PT64907B (fr) 1978-03-24
AU505355B2 (en) 1979-11-15
AU1204976A (en) 1977-09-22
JPS51115910A (en) 1976-10-13
CA1073358A (en) 1980-03-11
SE7603325L (sv) 1976-09-18
NL190313B (nl) 1993-08-16
GB1546448A (en) 1979-05-23
GR60341B (en) 1978-05-17
AT353415B (de) 1979-11-12
ATA192276A (de) 1979-04-15
NZ180321A (en) 1978-06-20
DE2611041A1 (de) 1976-10-14
ES446075A1 (es) 1977-09-16
MC1101A1 (fr) 1977-02-04
NL190313C (nl) 1994-01-17
NL7602776A (nl) 1976-09-21
LU74558A1 (ja) 1977-09-27
DE2611041C2 (ja) 1988-06-09
IE43083B1 (en) 1980-12-17
PH14927A (en) 1982-01-29
CH630257A5 (en) 1982-06-15
PT64907A (fr) 1976-04-01

Similar Documents

Publication Publication Date Title
SE433804B (sv) Forfarande for framstellning av en farmaceutisk lekemedelsberedning i kapselform med retardeffekt
SE423967B (sv) Forfarande for framstellning av porosa tabletter
SE442295B (sv) Forfarande for framstellning av 4-amino-5-en-hexansyra
SE429655B (sv) Forfarande for framstellning av 4'-deoxidauromycin hydroklorid
DK562276A (da) Fremgangsmaade til fremstilling af en farmaceutisk administrationsform
SE431089B (sv) Forfarande for framstellning av beta-metyltio-propionaldehyd
NO146044C (no) Fremgangsmaate for fremstilling av et farmasoeytisk insulin-preparat for rektal bruk
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE7613768L (sv) Forfarande for framstellning av penicillinestrar
SE423390B (sv) Foerfarande foer framstaellning av eburnameninderivat
DK98076A (da) Fremgangsmade til fremstilling af et farmaceutisk preparat
NO147672C (no) Analogifremgangsmaate for fremstilling av n-aryl-n-(1-l1-4-piperidinyl)-arylacetamider
RO69885A (ro) Procedeu de preparare a l-piroglutamil-l-prolinamidei
SE7705851L (sv) Forfarande for framstellning av en farmaceutisk komposition
SE439159B (sv) Forfarnde for framstellning av nya 5-fluoropyrimidin-4-on-derivat
SE420093B (sv) Forfarande for framstellning av 5-fenyl-2-furamidoximer
SE7605751L (sv) Forfarande for framstellning av en bensotiazinforening
IT1068946B (it) Procedimento per prepararae triemtilidrochinone
SE7803456L (sv) Forfarande for framstellning av en farmaceutisk komposition
SE434156B (sv) Forfarande for framstellning av penicilliner
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
SE413243B (sv) Forfarande for framstellning av vissa angivna farmaceutiskt anvendbara aminoalkanol-derivat
SE7705850L (sv) Forfarande for framstellning av en farmaceutisk komposition
SE7601836L (sv) Forfarande for framstellning av ett dimerkaptoeltyleterderivat
SE414927B (sv) Forfarande for framstellning av 1-metyl-2-(fenyloximetyl)-5-nitroimidazoler

Legal Events

Date Code Title Description
SPCF Application for supplementary protection certificate filed

Free format text: 7603325

NAL Patent in force

Ref document number: 7603325-7

SPCG Supplementary protection certificate granted

Free format text: 9490073, 920103, EXPIRES: 20010316

NUG Patent has lapsed

Ref document number: 7603325-7